Useful links
Unit of study_
PHAR4813: Novel Therapeutics
2024 unit information
This unit of study expands on second and third year pharmaceutical science (Medicinal Chemistry, Pharmaceutics, Pharmacology, Biology and Biochemistry) by exposing students to drug development and developing biotechnologies, new drug targets and therapies as well as clinical trials. Students will be introduced to emerging biotechnologies and biological devices including drug delivery systems, new drug targets and therapies in order to be aware of "up and coming" biotechnologies and how they will impact on pharmaceutical care. Such knowledge will help students to decide their future career direction and give more understanding of practical problems encountered in design and use of biotechnology derived drugs. In addition, this unit of study promotes integration and application of prior knowledge in pharmaceutical science to solving problems in tasks encountered in research and development. This unit will help to understand pharmaceutical drug development as a possible career path and prepares students for professional accreditation. Students will develop knowledge related to biotechnology derived drugs and develop skills in obtaining and critically assessing peer-reviewed publications, as well as people skills from group work, conflict management and written and oral communication skills.
Unit details and rules
Managing faculty or University school:
Pharmacy
| Code | PHAR4813 |
|---|---|
| Academic unit | Pharmacy |
| Credit points | 6 |
|
Prerequisites:
?
|
PHAR3100 and PHAR3815 and PHAR3825 and PHAR3816 and PHAR3817 and PHAR3818 and PHAR3819 and PHAR3826 and PHAR3827 and PHAR3820 and PHAR4100 |
|---|---|
|
Corequisites:
?
|
PHAR4821 and (PHAR4820 or PHAR4822) |
| Prohibitions:
?
|
None |
| Assumed knowledge:
?
|
None |
At the completion of this unit, you should be able to:
- LO1. use scientific databases to obtain relevant information about new and developing biotechnologies in peer-reviewed publications and text books
- LO2. critically assess the scientific information from peer-reviewed publications and text books
- LO3. demonstrate an awareness of current biotechnologies and their impact on pharmaceutical health
- LO4. explain the principles involved in drug discovery and the decision-making process involved in developing drugs
- LO5. understand the principles involved in the formulation of new drugs
- LO6. describe and interpret bioavailability/bioequivalence studies
- LO7. creatively design novel approaches to deliver drugs combining emerging research and technological tools
- LO8. make appropriate clinical decisions on drug/drug dosage choice based on biopharmaceutic, pharmacokinetic and pharmacodynamic considerations
- LO9. understand the broader concept of education as outlined in the University’s policy on generic attributes
- LO10. work in a team to achieve a better understanding of molecular principles involved in drug development
- LO11. demonstrate improved written and oral communication.
Unit availability
This section lists the session, attendance modes and locations the unit is available in. There is a unit outline for each of the unit availabilities, which gives you information about the unit including assessment details and a schedule of weekly activities.
The outline is published 2 weeks before the first day of teaching. You can look at previous outlines for a guide to the details of a unit.
| Session | MoA ? | Location | Outline ? |
|---|---|---|---|
|
Semester 2 2024
|
Normal day | Camperdown/Darlington, Sydney |
Outline unavailable
|
Modes of attendance (MoA)
This refers to the Mode of attendance (MoA) for the unit as it appears when you’re selecting your units in Sydney Student. Find more information about modes of attendance on our website.
